136 related articles for article (PubMed ID: 8856122)
1. Potentiation of the biological efficacy of bradykinin by ACE inhibitors: a shift in the affinity of the B2 receptor?
Hecker M; Bara AT; Busse R
Immunopharmacology; 1996 Jun; 33(1-3):93-4. PubMed ID: 8856122
[TBL] [Abstract][Full Text] [Related]
2. ACE inhibitor potentiation of bradykinin-induced venoconstriction.
Hecker M; Blaukat A; Bara AT; Müller-Esterl W; Busse R
Br J Pharmacol; 1997 Aug; 121(7):1475-81. PubMed ID: 9257930
[TBL] [Abstract][Full Text] [Related]
3. Potentiation by ACE inhibitors of the dilator response to bradykinin in the coronary microcirculation: interaction at the receptor level.
Hecker M; Pörsti I; Bara AT; Busse R
Br J Pharmacol; 1994 Jan; 111(1):238-44. PubMed ID: 8012702
[TBL] [Abstract][Full Text] [Related]
4. Potentiation of kinin analogues by ramiprilat is exclusively related to their degradation.
Dendorfer A; Reibetamann S; Wolfrum S; Raasch W; Dominiak P
Hypertension; 2001 Jul; 38(1):142-6. PubMed ID: 11463775
[TBL] [Abstract][Full Text] [Related]
5. Studies on the angiotensin-converting enzyme and the kinin B2 receptor in the rabbit jugular vein: modulation of contractile response to bradykinin.
Gobeil F; Hallé S; Blais PA; Regoli D
Can J Physiol Pharmacol; 2002 Feb; 80(2):153-63. PubMed ID: 11934258
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-converting enzyme inhibitor ramiprilat interferes with the sequestration of the B2 kinin receptor within the plasma membrane of native endothelial cells.
Benzing T; Fleming I; Blaukat A; Müller-Esterl W; Busse R
Circulation; 1999 Apr; 99(15):2034-40. PubMed ID: 10209009
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of the vascular response to kinins by inhibition of myocardial kininases.
Dendorfer A; Wolfrum S; Schäfer U; Stewart JM; Inamura N; Dominiak P
Hypertension; 2000 Jan; 35(1 Pt 1):32-7. PubMed ID: 10642271
[TBL] [Abstract][Full Text] [Related]
8. Bradykinin potentiation by angiotensin-(1-7) and ACE inhibitors correlates with ACE C- and N-domain blockade.
Tom B; de Vries R; Saxena PR; Danser AH
Hypertension; 2001 Jul; 38(1):95-9. PubMed ID: 11463767
[TBL] [Abstract][Full Text] [Related]
9. ACE inhibitor and AT1 antagonist blockade of deformation-induced gene expression in the rabbit jugular vein through B2 receptor activation.
Lauth M; Cattaruzza M; Hecker M
Arterioscler Thromb Vasc Biol; 2001 Jan; 21(1):61-6. PubMed ID: 11145934
[TBL] [Abstract][Full Text] [Related]
10. Role of endothelium-derived bradykinin in the control of vascular tone.
Hecker M; Dambacher T; Busse R
J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S55-61. PubMed ID: 1282631
[TBL] [Abstract][Full Text] [Related]
11. Relaxation of isolated coronary arteries by angiotensin-converting enzyme inhibitors: role of endothelium-derived kinins.
Hecker M; Bara AT; Busse R
J Vasc Res; 1993; 30(5):257-62. PubMed ID: 8399986
[TBL] [Abstract][Full Text] [Related]
12. The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors.
Hartman JC
Ann Thorac Surg; 1995 Sep; 60(3):789-92. PubMed ID: 7545893
[TBL] [Abstract][Full Text] [Related]
13. Direct effects of the angiotensin-converting enzyme inhibitor ramiprilat on adult rat ventricular cardiomyocytes.
Helmig S; Schuckenböhmer P; Heger J; Euler G; Piper HM; Schlüter KD
Acta Physiol (Oxf); 2007 Dec; 191(4):267-74. PubMed ID: 17825088
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of endothelial autacoid formation by inhibitors of angiotensin-converting enzyme.
Hecker M; Benzing T; Busse R
Agents Actions Suppl; 1992; 38 ( Pt 3)():163-70. PubMed ID: 1281378
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting enzyme inhibitors unmask endogenous kinin production by bovine coronary artery endothelium.
Hecker M; Bara AT; Busse R
Eur Heart J; 1993 Nov; 14 Suppl I():161-3. PubMed ID: 8293768
[TBL] [Abstract][Full Text] [Related]
16. Endothelium-derived bradykinin: implications for angiotensin-converting enzyme-inhibitor therapy.
Busse R; Fleming I; Hecker M
J Cardiovasc Pharmacol; 1993; 22 Suppl 5():S31-6. PubMed ID: 7508049
[TBL] [Abstract][Full Text] [Related]
17. Induction of functional bradykinin b(1)-receptors in normotensive rats and mice under chronic Angiotensin-converting enzyme inhibitor treatment.
Marin-Castaño ME; Schanstra JP; Neau E; Praddaude F; Pecher C; Ader JL; Girolami JP; Bascands JL
Circulation; 2002 Feb; 105(5):627-32. PubMed ID: 11827930
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of angiotensin-converting enzyme reduces rat liver reperfusion injury via bradykinin-2-receptor.
Freise H; Palmes D; Spiegel HU
J Surg Res; 2006 Aug; 134(2):231-7. PubMed ID: 16513137
[TBL] [Abstract][Full Text] [Related]
19. Bradykinin, angiotensin-(1-7), and ACE inhibitors: how do they interact?
Tom B; Dendorfer A; Danser AH
Int J Biochem Cell Biol; 2003 Jun; 35(6):792-801. PubMed ID: 12676166
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of bradykinin and resensitization of its B2 receptor.
Marcic B; Deddish PA; Jackman HL; Erdös EG
Hypertension; 1999 Mar; 33(3):835-43. PubMed ID: 10082496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
